|
19 Companies |
|
16 Products |
|
16 Products |
|
27 Mechanisms of Action |
|
1 Trial |
|
40 News |
|
| «12 |
- Azedra (iobenguane I 131) / Lantheus
New P2 trial, Metastases: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors (clinicaltrials.gov) - Aug 7, 2011
P2, N=50, Completed, Sponsor: University of California, San Francisco